A mixture of Lactobacillus species isolated from traditional fermented foods promote recovery from antibiotic-induced intestinal disruption in mice

J Appl Microbiol. 2018 Mar;124(3):842-854. doi: 10.1111/jam.13687. Epub 2018 Feb 6.

Abstract

Aims: This study evaluated the antibiotic-induced changes in microbial ecology, intestinal dysbiosis and low-grade inflammation; and the combined effect of four different Lactobacillus species on recovery of microbiota composition and improvement of gut barrier function in mice.

Methods and results: Administration of the antibiotic ampicillin for 2 weeks decreased microbial community diversity, induced caecum tumefaction and increased gut permeability in mice. Application of a probiotic cocktail of four Lactobacillus species (JUP-Y4) modulated the microbiota community structure and promoted the abundance of potentially beneficial bacteria such as Akkermansia. Ampicillin administration led to a decline in Bacteroidetes from 46·6 ± 3·91% to 0·264 ± 0·0362%; the addition of JUP-Y4 restored this to 41·4 ± 2·87%. This probiotic supplementation was more effective than natural restoration, where the levels of Bacteroidetes were only restored to 29·3 ± 2·07%. Interestingly, JUP-Y4 treatment was more effective in the restoration of microbiota in faecal samples than in caecal samples. JUP-Y4 also significantly reduced the levels of d-lactate and endotoxin (lipopolysaccharide, LPS) in the serum of mice, and increased the expression of tight-junction proteins while reducing the production of inflammatory cytokines (TNF-α, IL-6, MCP-1, IFN-γ and IL-1β) in the ileum and the colon of antibiotic-treated mice.

Conclusions: JUP-Y4 not only promoted recovery from antibiotic-induced gut dysbiosis, but also enhanced the function of the gut barrier, reduced inflammation and lowered levels of circulating endotoxin in mice.

Significance and impact of the study: Consumption of a mixture of Lactobacillus species may encourage faster recovery from antibiotic-induced gut dysbiosis and gut microbiota-related immune disturbance.

Keywords: Lactobacillus; antibiotics; diseases; immunology; intestinal microbiota.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / pharmacology
  • Brassica / microbiology*
  • Cecum / immunology
  • Cecum / microbiology
  • Colon / immunology
  • Colon / microbiology
  • Cytokines / genetics
  • Cytokines / immunology
  • Fermented Foods / microbiology*
  • Gastrointestinal Microbiome / drug effects*
  • Humans
  • Ileum / immunology
  • Ileum / microbiology
  • Intestinal Diseases / drug therapy*
  • Intestinal Diseases / etiology
  • Intestinal Diseases / immunology
  • Intestinal Diseases / microbiology
  • Intestinal Mucosa / metabolism
  • Intestines / microbiology
  • Lactobacillus / genetics
  • Lactobacillus / isolation & purification
  • Lactobacillus / physiology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Probiotics / administration & dosage*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Bacterial Agents
  • Cytokines
  • Tumor Necrosis Factor-alpha